Musculoskeletal disorders (MSD) impose a growing societal burden. Although many new therapeutic options are available, questions on effectiveness, efficiency, and equity of care remain unanswered. This is reflected by the inclusion of the major MSDs of arthritis and metabolic bone disease as the theme for our CERTs. MSDs exert an especially heavy toll on the elderly and other disadvantaged and underserved subpopulations, including racial/ethnic minorities, children, &persons with co-morbidities. Study of these groups constitutes our sub-theme. During past AHRQ funding, we conducted >50 projects creating new knowledge and products, disseminating findings, and improving public health.
The specific aims of the proposed Deep South Arthritis and Musculoskeletal (DSAM) CERTs are to: 1) Improve safety and effectiveness of MSD therapeutics through 4 projects (partners in parentheses) that build on our past work and address the programmatic areas of comparative effectiveness research (CER), tool development, health systems interventions and translating research into practice. These projects, which will directly impact patient outcomes dung this period of funding, include: (a) Comparative Effectiveness of NSAIDs vs. Narcotics after Joint Replacement Surgery (FORCE registry &UMass)- will lead to more effective and safer use of analgesics post-arthroplasty;(b) A Novel Tool and Multi-Modal Intervention for Improving Osteoporosis Treatment Adherence (Kaiser)- will increase therapeutic adherence among those at highest risk for non-adherence (will lead to lower rate of fractures);(c) Informed Consent Tools for Pragmatic Clinical Trials in Musculoskeletal Diseases (CMTP &JHU)- will yield tools for future important efforts in CER;and (d) Assessing Comparative Effectiveness of Biologics and Communicating Risk in Juvenile and Adult Inflammatory Arthritis (CARRA and Yale U)- will generate knowledge about risks of biologist and more effectively communicate risk leading to better arthritis outcomes;2) Educate health care practitioners, patients, caregivers, pavers, and policy makers while implementing and disseminating our research and educational portfolio;and 3) Develop concept briefs and other nascent research and education ideas into full scale projects and products for dissemination in cooperation with AHRQ, the CERTs Scientific Forum, and our large network of partners. With our talented investigator pool and through our Cores, we provide the infrastructure and proven expertise to successfully carryout this multi-disciplinary program of hypothesis testing research and tool development to improve regional and national MSD health care quality.

Public Health Relevance

Arthritis and other musculoskeletal disorder impose to a growing societal burden. Although many new therapies are available, many questions on their effectiveness and safety remain unanswered. To improve patient outcomes and public health, the UAB Deep South Arthritis and Musculoskeletal CERTs will conduct research and develop products to answer questions and fill other unmet needs in this critical area

Agency
National Institute of Health (NIH)
Institute
Agency for Healthcare Research and Quality (AHRQ)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19HS021110-01
Application #
8265066
Study Section
Special Emphasis Panel (ZHS1-HSR-X (03))
Program Officer
Wittenberg, Kim
Project Start
2011-09-30
Project End
2016-08-31
Budget Start
2011-09-30
Budget End
2012-08-31
Support Year
1
Fiscal Year
2011
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Beukelman, Timothy; Xie, Fenglong; Chen, Lang et al. (2018) Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitors. Ann Rheum Dis 77:1012-1016
Singh, Jasvinder A; Hossain, Alomgir; Mudano, Amy S et al. (2017) Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. Cochrane Database Syst Rev 5:CD012657
Weech-Maldonado, Robert; Miller, Michael J; Lord, Justin C (2017) The Relationships Among Socio-Demographics, Perceived Health, and Happiness. Appl Res Qual Life 12:289-302
Singh, Jasvinder A; Hossain, Alomgir; Tanjong Ghogomu, Elizabeth et al. (2017) Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis. Cochrane Database Syst Rev 3:CD012591
Lemay, Celeste A; Lewis, Courtland G; Singh, Jasvinder A et al. (2017) Receipt of Pain Management Information Preoperatively Is Associated With Improved Functional Gain After Elective Total Joint Arthroplasty. J Arthroplasty 32:1763-1768
Houser, Shannon H; Au, David W; Miller, Michael J et al. (2016) Socio-demographic differences in risk information seeking sources for non-steroidal anti-inflammatory drugs (NSAIDS). Int J Med Inform 94:222-7
Scott, Frank I; Mamtani, Ronac; Brensinger, Colleen M et al. (2016) Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer. JAMA Dermatol 152:164-72
Mannion, Melissa L; Xie, Fenglong; Baddley, John et al. (2016) Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients. Pediatr Rheumatol Online J 14:49
Mamtani, Ronac; Clark, Amy S; Scott, Frank I et al. (2016) Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study. Arthritis Rheumatol 68:2403-11
Beukelman, Timothy; Xie, Fenglong; Baddley, John W et al. (2016) The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis. Arthritis Res Ther 18:210

Showing the most recent 10 out of 31 publications